Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsExchange Transfusion, Whole BloodGraft vs Host DiseaseBone and BonesBlood DonorsTransplantation ChimeraBlood TransfusionHematopoietic Stem Cell TransplantationTransplantation ConditioningTransplantation, AutologousWhole-Body IrradiationTissue DonorsMice, Inbred C57BLAnemia, AplasticLeukemiaBone Marrow DiseasesHematopoietic Stem CellsBone Marrow PurgingABO Blood-Group SystemGraft SurvivalBone Marrow ExaminationBone RemodelingBusulfanLiver TransplantationHistocompatibility TestingBone Marrow NeoplasmsHistocompatibilityHematopoiesisTransplantation, IsogeneicCyclophosphamideRadiation ChimeraBone DensityLeukemia, Myeloid, AcuteRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic NeoplasmsCombined Modality TherapyTime FactorsKidney TransplantationTreatment OutcomeBloodGraft RejectionRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressive AgentsColony-Forming Units AssayT-LymphocytesBone ResorptionGraft vs Host ReactionStem Cell TransplantationLeukemia, MyeloidTransplantation ImmunologyLymphocyte DepletionImmunosuppressionCell DifferentiationHepatic Veno-Occlusive DiseaseAcute DiseaseLeukocyte TransfusionMyelodysplastic SyndromesChimeraLymphoma, Non-HodgkinSpleenCells, CulturedHLA AntigensSurvival AnalysisRetrospective StudiesFlow CytometryBone NeoplasmsMice, Inbred BALB CLiving DonorsHematologic DiseasesSevere Combined ImmunodeficiencyGraft vs Tumor EffectHeart TransplantationPancytopeniaGranulocyte Colony-Stimulating FactorMultiple MyelomaCyclosporineGraft vs Leukemia EffectLeukocyte CountAntigens, CD34Bone DevelopmentActuarial AnalysisAntineoplastic Combined Chemotherapy ProtocolsBone DiseasesNuclear FamilyCytomegalovirus InfectionsSurvival RateGranulocytesFollow-Up StudiesLymphocyte TransfusionImmunophenotypingCytarabineLung TransplantationMice, KnockoutCell SeparationCarmustine